AAAAAA

   
Results: 1-23 |
Results: 23
Targeting of lymphotoxin-alpha to the tumor elicits an efficient immune response associated with induction of peripheral lymphoid-like tissue
Authors: Schrama, D Straten, PT Fischer, WH McLellan, AD Brocker, EB Reisfeld, RA Becker, JC
Citation: D. Schrama et al., Targeting of lymphotoxin-alpha to the tumor elicits an efficient immune response associated with induction of peripheral lymphoid-like tissue, IMMUNITY, 14(2), 2001, pp. 111-121
Induction of systemic CTL responses in melanoma patients by dendritic cellvaccination: Cessation of CTL responses is associated with disease progression
Authors: Andersen, MH Keikavoussi, P Brocker, EB Schuler-Thurner, B Jonassen, M Sondergaard, I Straten, PT Becker, JC Kampgen, E
Citation: Mh. Andersen et al., Induction of systemic CTL responses in melanoma patients by dendritic cellvaccination: Cessation of CTL responses is associated with disease progression, INT J CANC, 94(6), 2001, pp. 820-824
In situ cytokine therapy: redistribution of clonally expanded T cells
Authors: Straten, PT Guldberg, P Schrama, D Andersen, MH Moerch, U Seremet, T Siedel, C Reisfeld, RA Becker, JC
Citation: Pt. Straten et al., In situ cytokine therapy: redistribution of clonally expanded T cells, EUR J IMMUN, 31(1), 2001, pp. 250-258
Identification of a cytotoxic T lymphocyte response to the apoptosis inhibitor protein survivin in cancer patients
Authors: Andersen, MH Pedersen, LO Becker, JC Straten, PT
Citation: Mh. Andersen et al., Identification of a cytotoxic T lymphocyte response to the apoptosis inhibitor protein survivin in cancer patients, CANCER RES, 61(3), 2001, pp. 869-872
Oligoclonal T-cell receptor usage of melanocyte differentiation antigen-reactive T cells in stage IV melanoma patients
Authors: Schrama, D Andersen, MH Terheyden, P Schroder, L Pedersen, LO Straten, PT Becker, JC
Citation: D. Schrama et al., Oligoclonal T-cell receptor usage of melanocyte differentiation antigen-reactive T cells in stage IV melanoma patients, CANCER RES, 61(2), 2001, pp. 493-496
Spontaneous cytotoxic T-cell responses against survivin-derived MHC class I-restricted T-cell epitopes in situ as well as ex vivo in cancer patients
Authors: Andersen, MH Pedersen, LO Capeller, B Brocker, EB Becker, JC Straten, PT
Citation: Mh. Andersen et al., Spontaneous cytotoxic T-cell responses against survivin-derived MHC class I-restricted T-cell epitopes in situ as well as ex vivo in cancer patients, CANCER RES, 61(16), 2001, pp. 5964-5968
T-cell receptor clonotype mapping using denaturing gradient gel electrophoresis - Analysis of clonal T-cell responses in melanoma
Authors: Straten, PT Becker, JC Zeuthen, J Guldberg, P
Citation: Pt. Straten et al., T-cell receptor clonotype mapping using denaturing gradient gel electrophoresis - Analysis of clonal T-cell responses in melanoma, METH MOL M, 61, 2001, pp. 339-351
Tumor infiltrating lymphocytes in melanoma comprise high numbers of T-cellclonotypes that are lost during in vitro culture
Authors: Straten, PT Kirkin, AF Siim, E Dahlstrom, K Drzewiecki, KT Seremet, T Zeuthen, J Becker, JC Guldberg, P
Citation: Pt. Straten et al., Tumor infiltrating lymphocytes in melanoma comprise high numbers of T-cellclonotypes that are lost during in vitro culture, CLIN IMMUNO, 96(2), 2000, pp. 94-99
Aberrant p27(Kip1) promoter methylation in malignant melanoma
Authors: Worm, J Bartkova, J Kirkin, AF Straten, PT Zeuthen, J Bartek, J Guldberg, P
Citation: J. Worm et al., Aberrant p27(Kip1) promoter methylation in malignant melanoma, ONCOGENE, 19(44), 2000, pp. 5111-5115
Comparative delineation of T cell clonotypes in coexisting syngeneic B16 melanoma
Authors: Moerch, U Schrama, D Guldberg, P Seremet, T Zeuthen, J Becker, JC Straten, PT
Citation: U. Moerch et al., Comparative delineation of T cell clonotypes in coexisting syngeneic B16 melanoma, CANCER IMMU, 49(8), 2000, pp. 426-432
Cytotoxic T-lymphocyte clones, established by stimulation with the HLA-A2 binding p53(65-73) wild type peptide loaded on dendritic cells in vitro, specifically recognize and lyse HLA-A2 tumour cells overexpressing the p53 protein
Authors: Barfoed, AM Petersen, TR Kirkin, AF Straten, PT Claesson, MH Zeuthen, J
Citation: Am. Barfoed et al., Cytotoxic T-lymphocyte clones, established by stimulation with the HLA-A2 binding p53(65-73) wild type peptide loaded on dendritic cells in vitro, specifically recognize and lyse HLA-A2 tumour cells overexpressing the p53 protein, SC J IMMUN, 51(2), 2000, pp. 128-133
T-cell clonality in immune responses
Authors: Becker, JC Straten, PT
Citation: Jc. Becker et Pt. Straten, T-cell clonality in immune responses, IMMUNOL TOD, 21(2), 2000, pp. 107-107
Expression of CD94/NKG2 subtypes on tumor-infiltrating lymphocytes in primary and metastatic melanoma
Authors: Vetter, CS Straten, PT Terheyden, P Zeuthen, J Brocker, EB Becker, JC
Citation: Cs. Vetter et al., Expression of CD94/NKG2 subtypes on tumor-infiltrating lymphocytes in primary and metastatic melanoma, J INVES DER, 114(5), 2000, pp. 941-947
Anti-melanocyte T cell responses - Methodology versus biology
Authors: Straten, PT Guldberg, P Moerch, U Becker, JC
Citation: Pt. Straten et al., Anti-melanocyte T cell responses - Methodology versus biology, J INVES DER, 114(4), 2000, pp. 738-739
CD40-ligated dendritic cells effectively expand melanoma-specific CD8(+) CTLs and CD4(+) IFN-gamma-producing T cells from tumor-infiltrating lymphocytes
Authors: Terheyden, P Straten, PT Brocker, EB Kampgen, E Becker, JC
Citation: P. Terheyden et al., CD40-ligated dendritic cells effectively expand melanoma-specific CD8(+) CTLs and CD4(+) IFN-gamma-producing T cells from tumor-infiltrating lymphocytes, J IMMUNOL, 164(12), 2000, pp. 6633-6639
Differential expression of CD28 and CD94/NKG2 on T cells with identical TCR beta variable regions in primary melanoma and sentinel lymph node
Authors: Becker, JC Vetter, CS Schrama, D Brocker, EB Straten, PT
Citation: Jc. Becker et al., Differential expression of CD28 and CD94/NKG2 on T cells with identical TCR beta variable regions in primary melanoma and sentinel lymph node, EUR J IMMUN, 30(12), 2000, pp. 3699-3706
Quantification of melanoma cell-specific MART-I mRNA in peripheral blood by a calibrated competitive reverse transcription-PCR
Authors: Sorensen, BS Schmidt, H von der Maase, H Straten, PT Nexo, E
Citation: Bs. Sorensen et al., Quantification of melanoma cell-specific MART-I mRNA in peripheral blood by a calibrated competitive reverse transcription-PCR, CLIN CHEM, 46(12), 2000, pp. 1923-1928
Somatic mutation of the Peutz-Jeghers syndrome gene, LKB1/STK11, in malignant melanoma
Authors: Guldberg, P Straten, PT Ahrenkiel, V Seremet, T Kirkin, AF Zeuthen, J
Citation: P. Guldberg et al., Somatic mutation of the Peutz-Jeghers syndrome gene, LKB1/STK11, in malignant melanoma, ONCOGENE, 18(9), 1999, pp. 1777-1780
Function and dysfunction of CD4(+) T cells in the immune response to melanoma
Authors: Fischer, WH Straten, PT Terheyden, P Becker, JC
Citation: Wh. Fischer et al., Function and dysfunction of CD4(+) T cells in the immune response to melanoma, CANCER IMMU, 48(7), 1999, pp. 363-370
In situ T cells in melanoma
Authors: Straten, PT Becker, JC Guldberg, P Zeuthen, J
Citation: Pt. Straten et al., In situ T cells in melanoma, CANCER IMMU, 48(7), 1999, pp. 386-395
Establishment of gp100 and MART-1/Melan-A-specific cytotoxic T lymphocyte clones using in vitro immunization against preselected highly immunogenic melanoma cell clones
Authors: Kirkin, AF Straten, PT Hansen, MR Barfoed, A Dzhandzhugazyan, KN Zeuthen, J
Citation: Af. Kirkin et al., Establishment of gp100 and MART-1/Melan-A-specific cytotoxic T lymphocyte clones using in vitro immunization against preselected highly immunogenic melanoma cell clones, CANCER IMMU, 48(5), 1999, pp. 239-246
Accumulation of identical T cells in melanoma and vitiligo-like leukoderma
Authors: Becker, JC Guldberg, P Zeuthen, J Brocker, EB Straten, PT
Citation: Jc. Becker et al., Accumulation of identical T cells in melanoma and vitiligo-like leukoderma, J INVES DER, 113(6), 1999, pp. 1033-1038
In situ T cell responses against melanoma comprise high numbers of locallyexpanded T cell clonotypes
Authors: Straten, PT Guldberg, P Gronbaek, K Hansen, MR Kirkin, AF Seremet, T Zeuthen, J Becker, JC
Citation: Pt. Straten et al., In situ T cell responses against melanoma comprise high numbers of locallyexpanded T cell clonotypes, J IMMUNOL, 163(1), 1999, pp. 443-447
Risultati: 1-23 |